New Lead Generation Strategies for Protein Kinase Inhibitors - Fragment Based Screening Approaches

Adrian      Gill

Abstract

The protein kinase superfamily represents both an enormous opportunity and a unique challenge for drug discovery. Protein kinases play central roles in the cellular economy and it is well known that a large number of diseases involve aberrant protein kinase activity. This review discusses how fragment based screening strategies, such as virtual screening, NMR and high-throughput X-ray crystallography are being employed to identify new chemo-types to produce the next generation of protein kinase inhibitors.

Keywords: kinase inhibitors, x-ray crystallography, lead generation, structure-based drug design, virtual screening

« Previous Next »